Safety, Tolerability and Therapeutic Efficacy of Topical ZEP-3 Ointment (1.0%) for the Treatment of Cold Sores

NCT02483182 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Labialis

Interventions

DRUG: ZEP-3 ointment 1.0%
DRUG: Acyclovir cream 5%

Sponsor

Shulov Innovate for Science Ltd. 2012